scispace - formally typeset
C

Chris J.L.M. Meijer

Researcher at VU University Amsterdam

Publications -  745
Citations -  83366

Chris J.L.M. Meijer is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Cervical cancer & Cervical intraepithelial neoplasia. The author has an hindex of 128, co-authored 733 publications receiving 78705 citations. Previous affiliations of Chris J.L.M. Meijer include VU University Medical Center & Academic Center for Dentistry Amsterdam.

Papers
More filters
Journal ArticleDOI

Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.

TL;DR: This study is the first to establish genome‐wide miRNA profiles in HPV‐positive self‐samples to identify miRNAs that can predict the presence of CIN3 and cervical cancer in self-samples and indicates that miRNA expression analysis offers a promising novel molecular triage strategy for CIN 3 and cervicalcancer detection applicable to self‐Samples.
Journal ArticleDOI

Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease

TL;DR: Follow‐up after treatment for high‐grade CIN can be improved by combining cytology with hrHPV testing, and total health‐care costs using cytology and hr HPV testing during follow‐up decreased when low‐risk women omit the 12 months visit.
Journal ArticleDOI

Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas.

TL;DR: It is concluded that neoplastic cells of EBV‐positive extranodal T‐NHLs always have a cytotoxic phenotype, supporting the view that EBV can infect CTLs.
Journal ArticleDOI

T cell infiltration and MHC I and II expression in the presence of tumor antigens : An immunohistochemical study in patients with serous epithelial ovarian cancer

TL;DR: It is found that granzyme-B, TIA-1 and CD45RO+ T cells are present in the tumor biopsies, increasing this number by immunotherapy may be beneficial, and the immune escape mechanism by MHC class I and beta2m downregulation seems to be of minor importance.